EFFECT OF UPADACITINIB ON INTENSITY OF SCORAD ITEMS AND IMPACTS TO ITCH AND SLEEP: ANALYSIS FROM THE MEASURE UP 1 AND MEASURE UP 2 STUDIES

被引：0
|
作者：
Cameron, Michael [1 ]
Magnolo, Nina [2 ]
Prajapati, Vimal H. [3 ]
Haque, Adel [4 ]
Lee, Wan-Ju [5 ]
Altman, Katherine [5 ]
Platt, Andrew M. [5 ]
Lane, Michael C. [5 ]
Calimlim, Brian M. [5 ]
Taieb, Alain [6 ]
机构：
[1] Mt Sinai Hosp, Dept Dermatol, New York, NY USA
[2] Univ Hosp Munster, Dept Dermatol, Munster, Germany
[3] Univ Calgary, Div Dermatol, Dept Med, Calgary, AB, Canada
[4] Jefferson Hlth Northeast, Dept Med, Jefferson, AR USA
[5] AbbVie Inc, N Chicago, IL USA
[6] Univ Bordeaux, INSERM 1312, Bordeaux, France
来源：
ACTA DERMATO-VENEREOLOGICA | 2023年 / 103卷
关键词：
D O I：
暂无
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
P10.18
引用
收藏
页码：56 / 57
页数：2
相关论文
共 50 条
  • [1] Effect of upadacitinib on SCORAD intensity items: analysis from the Measure Up 1 and Measure Up 2 studies
    Cameron, Michael
    Magnolo, Nina
    Prajapati, Vimal H.
    Haque, Adel
    Lee, Wan-Ju
    Altman, Katherine
    Platt, Andrew M.
    Lane, Michael C.
    Calimlim, Brian M.
    Taieb, Alain
    BRITISH JOURNAL OF DERMATOLOGY, 2023, 188
  • [2] The effect of upadacitinib on the genital region in moderate-to-severe atopic dermatitis: an analysis from the Measure Up 1 and Measure Up 2 studies
    Cather, Jennifer
    Magnolo, Nina
    Cameron, Michael
    Calimlim, Brian
    Lane, Michael
    Hays, Stephanie
    Gamelli, Amy
    Woo, Yu Ri
    BRITISH JOURNAL OF DERMATOLOGY, 2023, 188
  • [3] Improvement in Itch, Symptoms, and Quality of Life With Upadacitinib Through Week 16 in Adults and Adolescents With Atopic Dermatitis: Results From Phase 3 Studies (Measure Up 1, Measure Up 2, and AD Up)
    Lio, Peter
    Eichenfield, Lawrence F.
    Marcoux, Danielle
    Lee, Wan-Ju
    Teixeira, Henrique D.
    Raymundo, Eliza M.
    Gamelli, Amy E.
    Grada, Ayman
    Hu, Xiaofei
    Irvine, Alan D.
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2023, 89 (03) : AB178 - AB178
  • [4] Upadacitinib in moderate-to-severe atopic dermatitis: combined safety analysis of phase III studies (Measure Up 1, Measure Up 2 and AD Up)
    Guttman-Yassky, Emma
    Irvine, A. D.
    Silverberg, J. I.
    Papp, K. A.
    Paller, A. S.
    Waterhouse, B.
    Tenorio, A. R.
    Ladizinski, B.
    Chu, A. D.
    Liu, J.
    Reich, Kristian
    BRITISH JOURNAL OF DERMATOLOGY, 2021, 185 (03) : E123 - E124
  • [5] Upadacitinib in moderate-to-severe atopic dermatitis: Combined safety analysis of phase 3 studies (Measure Up 1, Measure Up 2, and AD Up)
    Guttman-Yassky, Emma
    Irvine, Alan D.
    Silverberg, Jonathan I.
    Papp, Kim A.
    Paller, Amy S.
    Waterhouse, Brian
    Tenorio, Allan R.
    Ladizinski, Barry
    Chu, Alvina D.
    Liu, John
    Reich, Kristian
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2021, 85 (03) : AB129 - AB129
  • [6] 413 Improvement in itch, symptoms and quality of life with upadacitinib through week 16 in adults and adolescents with atopic dermatitis: results from phase 3 studies (Measure Up 1, Measure Up 2 and AD Up)
    Lio, Peter
    Eichenfield, Lawrence F.
    Marcoux, Danielle
    Lee, Wan-Ju
    Teixeira, Henrique D.
    Raymundo, Eliza M.
    Gamelli, Amy E.
    Grada, Ayman
    Hu, Xiaofei
    Irvine, Alan D.
    BRITISH JOURNAL OF DERMATOLOGY, 2023, 188
  • [7] Rapid itch improvement with upadacitinib with or without concomitant topical corticosteroids in moderate-to-severe atopic dermatitis: results from three phase III studies (Measure Up 1, Measure Up 2 and AD Up)
    Blauvelt, A.
    Ardern-Jones, M. R.
    Bieber, T.
    Hong, C.
    Chu, C. -Y.
    Liu, M.
    Yang, Y.
    Ladizinski, B.
    Teixeira, H. D.
    Calimlim, B. M.
    Thyssen, J. P.
    BRITISH JOURNAL OF DERMATOLOGY, 2021, 185 (03) : E117 - E118
  • [8] Efficacy of upadacitinib for moderate-to-severe atopic dermatitis: analysis of time spent in skin clearance response states from the Measure Up 1, Measure Up 2 and Heads Up studies
    Blauvelt, Andrew
    Silverberg, Jonathan, I
    Calimlim, Brian M.
    Liu, Yingyi
    Platt, Andrew
    Thyssen, Jacob P.
    BRITISH JOURNAL OF DERMATOLOGY, 2023, 188
  • [9] Rapid itch improvement with upadacitinib with or without concomitant topical corticosteroids (TCS) in moderate-to-severe atopic dermatitis (AD): Results from 3 phase 3 studies (Measure Up 1, Measure Up 2, and AD Up)
    Blauvelt, Andrew
    Ardern-Jones, Michael R.
    Bieber, Thomas
    Hong, Chih-Ho
    Chu, Chia-Yu
    Liu, Meng
    Yang, Yang
    Ladizinski, Barry
    Teixeira, Henrique D.
    Calimlim, Brian M.
    Thyssen, Jacob P.
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2021, 85 (03) : AB171 - AB171
  • [10] Sustained Improvement Over 52 Weeks in Patient-Reported Itch, Symptoms, and Quality of Life With Upadacitinib in Patients With Atopic Dermatitis: Results From Phase 3 Studies (Measure Up 1, Measure Up 2, and AD Up)
    Silverberg, Jonathan I.
    Deleuran, Mette
    Gold, Linda S.
    Bunick, Christopher G.
    Hijnen, Dirk Jan
    Calimlim, Brian M.
    Teixeira, Henrique D.
    Platt, Andrew M.
    Grada, Ayman
    Hu, Xiaofei
    Gooderham, Melinda
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2023, 89 (03) : AB90 - AB90
12345